Literature DB >> 1674436

The molecular genetics of familial venous thrombosis.

D N Cooper1.   

Abstract

Inherited defects of antithrombin III, protein C, protein S, heparin cofactor II, plasminogen and the fibrinogens are thought to be responsible for between 10 and 15% of all patients presenting with recurrent venous thrombosis. The structure, function and expression of these genes and the nature of the gene lesions underlying the deficiency states are reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674436     DOI: 10.1016/0268-960x(91)90009-2

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  5 in total

1.  A novel missense mutation in the antithrombin III gene (Ala387-->Val) causing recurrent venous thrombosis.

Authors:  D White; G Abraham; C Carter; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

2.  A novel missense mutation in the antithrombin III gene (Ser349----Pro) causing recurrent venous thrombosis.

Authors:  C B Grundy; S Holding; D S Millar; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Ligneous conjunctivitis: a clinicopathological, immunohistochemical, and genetic study including the treatment of two sisters with multiorgan involvement.

Authors:  M Teresa Rodríguez-Ares; Ihab Abdulkader; Ana Blanco; Rosario Touriño-Peralba; Clara Ruiz-Ponte; Ana Vega; José Cameselle-Teijeiro
Journal:  Virchows Arch       Date:  2007-08-15       Impact factor: 4.064

Review 4.  Thrombophilia: how far should a clotter be investigated?

Authors:  I D Walker
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

5.  Effect of microgravity on gene expression in mouse brain.

Authors:  Antonio Frigeri; Dumitru A Iacobas; Sanda Iacobas; Grazia Paola Nicchia; Jean Francois Desaphy; Diana Conte Camerino; Maria Svelto; David C Spray
Journal:  Exp Brain Res       Date:  2008-08-14       Impact factor: 1.972

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.